Advertisement

Topics

Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More

07:45 EDT 18 Aug 2017 | Xconomy

The CEO of a major U.S. pharmaceutical company was in the news this week, but for a change not because of the cost of drugs. Merck CEO Kenneth Frazier (pictured) was the first of what quickly became a line of CEOs to exit President Trump’s manufacturing council, leading to its dissolution altogether. Frazier was widely […]

Original Article: Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More

NEXT ARTICLE

More From BioPortfolio on "Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...